相关实验视频
Updated: Jul 1, 2025

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.7K
在患有先天性心脏病的妇女中,只有孕激素的避孕措施
Francesc Baró-Mariné1, Antonia Pijuan-Domènech2,3, Maria Del Mar Goya1
1Department of Obstetrics and Gynaecology, University Hospital Vall d'Hebron, Barcelona, Spain.
概括
长效可逆避孕药,如仅含孕激素的子宫内装置 (IUD-IP) 和皮下植入物 (SI-IP),对于患有先天性心脏病 (CHD) 的女性来说是安全有效的. 这些方法被推作为这群人群的第一线避孕选择.
科学领域:
- 生殖健康 生殖健康
- 心脏病学 心脏病学
- 避孕药是一种避孕药,用于避孕.
背景情况:
- 对于患有先天性心脏病 (CHD) 的患者仅使用孕激素避孕药的长期数据有限.
- 评估患有心血管疾病的妇女使用避孕药对生殖健康管理至关重要.
研究的目的:
- 评估各种避孕方法在患有心脏病的患者中的使用和有效性.
- 在这个队列中,比较短效可逆避孕药 (SARC) 与长效可逆避孕药 (LARC).
主要方法:
- 对653名参加预孕诊所的妇女进行了回顾性研究.
- 将避孕方法分类为有效性的TIER.
- 收集ESC和WHOMEC分类,用于安全和风险评估.
主要成果:
- 在咨询后,观察到对更有效的避孕方法 (TIER 2或1) 的显著转变.
- 199名患者使用口服仅含孕激素的药丸 (POP),53名患者使用宫内节育器 (IUD-IP),36名患者使用SI-IP.
- 使用POPs,IUD-IP和SI-IP的平均使用时间分别为58,59和53个月.
结论:
- 用孕激素浸的宫内器件 (IUD-IP) 和用孕激素浸的皮下植入物 (SI-IP) 显示出良好的安全性和有效性.
- IUD-IP和SI-IP被推作为患有心血管疾病的妇女的主要避孕选择.
相关概念视频
Birth Control Methods
248
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
248
Heart Failure Drugs: β-Blockers
338
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
338
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
181
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
181
Heart Failure Drugs: Inotropic Agents
586
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
586
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
523
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
523
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
743
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
743

